AKT1 and lung adenocarcinoma: Gong, C et al. found that NCAPG promoted the proliferation of hepatocellular carcinoma through the PI3K/AKT signaling pathway [41], and Wu, Y et al. found that NCAPG promoted the progression of lung adenocarcinoma through the transforming growth factor (TGF)-β signaling pathway [38].